Wall Street
This under-the-radar stock can surge more than 60% on a possible treatment for immuno-inflammatory diseases, Goldman Sachs says
Shares of Aclaris Therapeutics can surge more than 60% on the back of a possible new treatment for immuno-inflammatory diseases, including rheumatoid arthritis, according to Goldman Sachs. Analyst Corinne Jenkins initiated coverage of Aclaris Therapeutics with a buy rating, saying she expects promising results out of clinical trials for the company’s drug called zunsemetinib . […]
Read More
Goldman Sachs suggests this minimal-recognized biotech inventory can double on potentially ‘blockbuster’ earnings
Investors should really invest in biopharma stock Altimmune as it can double from below relying on the achievement of a new weight problems drug, in accordance to Goldman Sachs. Analyst Corinne Jenkins initiated protection of Altimmune with a invest in score, indicating she strongly expects a analyze on pemvidutide as a treatment for obesity will […]
Read More
GoodRx is a buy that can surge 60% from here, Citi says
The sell-off in telemedicine name GoodRx is overdone, and now is a good time to buy the stock, according to Citi. Analyst Daniel Grosslight initiated coverage on GoodRx with a buy rating, noting that the telemedicine company was created in reaction to a “complex and opaque” drug distribution channel for consumers that is unlikely to […]
Read More
Sell Ally Financial as shares could fall nearly 30% from here, Morgan Stanley says in downgrade
It’s time for investors to bail on Ally Financial , according to Morgan Stanley. Analyst Betsy Graseck downgraded the stock to underweight from equal weight, saying she has a cautious view on consumer credit heading into 2023 that will hurt companies such as Ally. The analyst said she expects that high inflation, rising unemployment and […]
Read More
Stocks earning the greatest moves just after hours: Salesforce, Snowflake, Costco, 5 Down below and a lot more
In this write-up 5 Price SNOW CRM Abide by your favourite sharesBuild Absolutely free ACCOUNT Signage on a Saleforce business office constructing in San Francisco, California, U.S., on Tuesday, Feb. 23, 2021. David Paul Morris | Bloomberg | Getty Images Look at out the providers earning headlines just after the bell: Salesforce — Salesforce’s inventory […]
Read More
View Fed Chair Jerome Powell talk on the economy and monetary plan
[The stream is slated to start at 1:30 p.m. ET. Please refresh the page if you do not see a player above at that time.] Federal Reserve Chair Jerome Powell is slated to communicate Wednesday at the Brookings Institution. His remarks will arrive as buyers search for clues on long run financial coverage moves by […]
Read More
This ‘defensive’ software stock could jump 70% going forward, Mizuho predicts
Investors should consider buying Intuit heading into 2023 as a defensive way of gaining exposure to the software sector, according to Mizuho. Analyst Siti Panigrahi reiterated a buy rating on Intuit after the company reported its latest quarterly results. The analyst said the company is set up to beat expectations next year after de-risking guidance […]
Read More
The most heavily shorted stocks include this little-known beauty company
Investors raised bets against Beauty Health Company , owner of the skincare brand HydraFacial, in the first half of November. As of Nov. 15, short interest in the beauty stock surged 26% to 32.8 million, or roughly 32% of its total float, according to FactSet data. Short interest as a percentage of float refers to […]
Read More
This little-known contact lenses stock can surge 20% from here, Baird says
There’s big upside in shares of Cooper Companies , a company known for manufacturing contact lenses, according to Baird. Analyst Jeff Johnson upgraded the stock to outperform, noting he sees a rosy outlook in 2023 for the company, even if it misses expectations in its fourth-quarter earnings report next week. “While we expect COO to […]
Read More
Bank of America downgrades Carvana, says stock could go to zero without a cash infusion
Hold off on Carvana for now as the stock could go one of two ways, according to Bank of America. Analyst Nat Schindler downgraded Carvana to neutral, saying that the online car retailer is badly in need of more liquidity as it struggles to turn profitable. “We now believe that without a cash infusion, Carvana […]
Read More